387
Views
50
CrossRef citations to date
0
Altmetric
Original Research

Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique

, , , , , , & show all
Pages 57-67 | Published online: 21 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Victoria Neches García, Laura Amanda Vallejo-Aparicio, Afisi S Ismaila, Antoni Sicras-Mainar, Aram Sicras-Navarro, Cruz González, Rafael Cuervo, Soham Shukla & Marcos García-Peñuela. (2022) Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2161-2174.
Read now
María Merino, Teresa Martín Lorenzo, Paulina Maravilla-Herrera, Julio Ancochea, José Tomás Gómez Sáenz, Nicole Hass, Jesús Molina, Germán Peces-Barba, Marta Trapero-Bertran, Juan Antonio Trigueros Carrero & Álvaro Hidalgo-Vega. (2022) A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1431-1442.
Read now
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Shahid Shah, Sameen Abbas, Irfhan Ali Bin Hyder Ali & Ahmad Salman. (2020) The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 661-672.
Read now
Antoni Sicras-Mainar, Francisco J de Abajo & José Luis Izquierdo-Alonso. (2020) Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3291-3302.
Read now
Sharareh Khosravi, Fatemeh Rafiei, Maryam Norozy, Ali Khanmohamadi Hezave & Maryam Ebrahimabadi. (2019) Cross-Cultural Adaptation Of The Persian Version Of Test Of The Adherence To Inhalers (TAI). Patient Preference and Adherence 13, pages 1693-1699.
Read now
Faustine Dalon, Gilles Devouassoux, Manon Belhassen, Gaëlle Nachbaur, Camille Correia Da Silva, Lynda Sail, Flore Jacoud, Christos Chouaid & Eric Van Ganse. (2019) Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2905-2915.
Read now
Faustine Dalon, Nicolas Roche, Manon Belhassen, Maëva Nolin, Hervé Pegliasco, Gaëtan Deslée, Bruno Housset, Philippe Devillier & Eric Van Ganse. (2019) Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1839-1854.
Read now
Ignacio Blanco, Isidro Diego, Patricia Bueno, Eloy Fernández, Francisco Casas-Maldonado, Cristina Esquinas, Joan B. Soriano & Marc Miravitlles. (2018) Geographical Distribution of COPD Prevalence in the Americas. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:4, pages 317-325.
Read now

Articles from other publishers (42)

Ignacio Blanco, Isidro Diego, César Castañón, Patricia Bueno & Marc Miravitlles. (2023) Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumología 59:7, pages 427-434.
Crossref
Dimitrios Tsimouris, Michail Arvanitidis, Maria Moutzouri, George A. Koumantakis, George Gioftsos, Maria Papandreou & Eirini Grammatopoulou. (2023) Is manual therapy of the diaphragm effective for people with obstructive lung diseases? A systematic review. Respiratory Medicine and Research 83, pages 101002.
Crossref
Hua Ye, Beibei He, Yujie Zhang, Ziwei Yu, Yifan Feng, Chuanbiao Wen, Chongcheng Xi & Quansheng Feng. (2023) Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease. Frontiers in Pharmacology 14.
Crossref
Vesna Milovanović, Tatjana Adžić-Vukičević, Marija Milić, Jelena Filimonović, Dragana Dimitrijević, Marina Jelić & Maja Stošić. (2023) The clinical features of pneumonia in patients with chronic obstructive pulmonary disease. Glasnik javnog zdravlja 97:1, pages 39-54.
Crossref
Sang Hyuk Kim, Hyun Lee, Youlim Kim, Chin Kook Rhee, Kyung Hoon Min, Yong Il Hwang, Deog Kyeom Kim, Yong Bum Park, Kwang Ha Yoo & Ji-Yong Moon. (2023) Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015–2019. Journal of Korean Medical Science 38:14.
Crossref
Fangzhen Li, Huaping Zhong, Kehui Ouyang, Xiaomin Zhao & Yuzhe Li. (2022) Estimation and Mapping of Actual and Potential Grassland Root Carbon Storage: A Case Study in the Altay Region, China. Agronomy 12:11, pages 2632.
Crossref
Anna Kowalczyk, Katarzyna Kosiek, Maciek Godycki-Cwirko & Izabela Zakowska. (2022) Community determinants of COPD exacerbations in elderly patients in Lodz province, Poland: a retrospective observational Big Data cohort study. BMJ Open 12:10, pages e060247.
Crossref
Hyunwoo Jeong, Soo Hyun Kim, Seongmi Choi & Heejung Kim. (2022) Nonadherence to health promotion depending on chronic obstructive pulmonary disease severity. Heart & Lung 55, pages 1-10.
Crossref
Hannah Whittaker, Eric Van Ganse, Faustine Dalon, Maeva Nolin, Claire Marant-Micallef, Christophe Pison, Dermot P Ryan, Gaetan Deslee, Jennifer K Quint & Manon Belhassen. (2022) Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. BMJ Open Respiratory Research 9:1, pages e001150.
Crossref
Rebecca F. Gilbert, Cody Cichowitz, Prossy Bibangambah, June-Ho Kim, Linda C. Hemphill, Isabelle T. Yang, Ruth N. Sentongo, Bernard Kakuhikire, David C. Christiani, Alexander C. Tsai, Samson Okello, Mark J. Siedner & Crystal M. North. (2022) Lung function and atherosclerosis: a cross-sectional study of multimorbidity in rural Uganda. BMC Pulmonary Medicine 22:1.
Crossref
Nikolaos Tzanakis, Nikolaos Koulouris, Katerina Dimakou, Konstantinos Gourgoulianis, Epameinondas Kosmas, Georgia Chasapidou, Athanasios Konstantinidis, Christos Kyriakopoulos, Theodoros Kontakiotis, Aggeliki Rapti, Mina Gaga, Konstantinos Kalafatakis & Konstantinos Kostikas. (2021) Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study. BMC Pulmonary Medicine 21:1.
Crossref
Qinghong Zhang, Chan-Pang Ng, Kan Dai, Jun Xu, Jian Tang, Juanzhen Sun & Mu Mu. (2021) Lessons Learned from the Tragedy during the 100 km Ultramarathon Race in Baiyin, Gansu Province on 22 May 2021. Advances in Atmospheric Sciences 38:11, pages 1803-1810.
Crossref
Linzy Houchen-Wolloff, Kerry A. Spitzer & Sarah Candy. 2021. Pulmonary Rehabilitation. Pulmonary Rehabilitation 258 272 .
Justė Jankevičienė & Arvydas Kanapickas. (2021) Projected Near-Surface Wind Speed Trends in Lithuania. Energies 14:17, pages 5425.
Crossref
Martine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, Jennifer Cook, Erkki Soini, Emma Paulsson & Maureen Rutten-van Mölken. (2021) Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study. BMJ Open 11:8, pages e049675.
Crossref
E. A. Orlova, A. R. Umerova, I. P. Dorfman, M. A. Orlov & M. A. Abdullaev. (2021) ЕSTIMATION OF SOCIO-ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR A 5-YEAR PERIOD: A REGIONAL ASPECT. Pharmacy & Pharmacology 9:2, pages 130-138.
Crossref
Ivet Bayes-Marin, Albert Sanchez-Niubo, Daniel Fernández, Josep Maria Haro & Beatriz Olaya. (2021) Risk of all-cause mortality associated with chronic obstructive pulmonary disease and the role of healthy ageing trajectories: a population-based study of middle-aged and older adults. BMJ Open 11:7, pages e050947.
Crossref
Sumitra Shantakumar, Yu-Fan Ho, Janine Beale & Barry Gribben. (2021) Burden of illness in blood eosinophilic phenotype COPD patients in New Zealand. Respiratory Investigation 59:4, pages 487-497.
Crossref
Alfredo Carrato, Davide Melisi, Gerald Prager, Christoph B Westphalen, Anabel Ferreras, Nathalie D’Esquermes, Julien Taieb & Teresa M Mercadé. (2021) Chart review of diagnostic methods, baseline characteristics and symptoms for European patients with pancreatic cancer. Future Oncology 17:15, pages 1843-1854.
Crossref
Shengnan Liu, Qiheng Zhao, Wenshuo Li, Xuetong Zhao & Kun Li. (2020) The Cost-Effectiveness of Pulmonary Rehabilitation for COPD in Different Settings: A Systematic Review. Applied Health Economics and Health Policy 19:3, pages 313-324.
Crossref
Emilie Fréalle, Gabriel Reboux, Olivier Le Rouzic, Nathalie Bautin, Marie-Capucine Willemin, Muriel Pichavant, Julie Delourme, Boualem Sendid, Philippe Gosset, Saad Nseir & Stéphanie Fry. (2021) Impact of domestic mould exposure on Aspergillus biomarkers and lung function in patients with chronic obstructive pulmonary disease. Environmental Research 195, pages 110850.
Crossref
Monika Gappa & Marek Lommatzsch. (2021) Transition bei chronisch obstruktiven Lungenerkrankungen von pädiatrischer in internistische lungenärztliche VersorgungTransition from pediatric to adult respiratory care in (patients with) chronic obstructive lung disease. Der Pneumologe 18:2, pages 75-85.
Crossref
Joan B. Soriano, Inmaculada Alfageme, Marc Miravitlles, Pilar de Lucas, Juan José Soler-Cataluña, Francisco García-Río, Ciro Casanova, José Miguel Rodríguez González-Moro, Borja G. Cosío, Guadalupe Sánchez & Julio Ancochea. (2021) Prevalence and Determinants of COPD in Spain: EPISCAN II. Archivos de Bronconeumología 57:1, pages 61-69.
Crossref
Joan B. Soriano, Inmaculada Alfageme, Marc Miravitlles, Pilar de Lucas, Juan José Soler-Cataluña, Francisco García-Río, Ciro Casanova, José Miguel Rodríguez González-Moro, Borja G. Cosío, Guadalupe Sánchez & Julio Ancochea. (2021) Prevalence and Determinants of COPD in Spain: EPISCAN II. Archivos de Bronconeumología (English Edition) 57:1, pages 61-69.
Crossref
Jaromir Zatloukal, Kristian Brat, Katerina Neumannova, Eva Volakova, Karel Hejduk, Eva Kocova, Ondrej Kudela, Michal Kopecky, Marek Plutinsky & Vladimir Koblizek. (2020) Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society. Biomedical Papers 164:4, pages 325-356.
Crossref
Jesper Weile, Christian A. Frederiksen, Christian B. Laursen, Ole Graumann, Erik Sloth & Hans Kirkegaard. (2020) Point-of-care ultrasound induced changes in management of unselected patients in the emergency department - a prospective single-blinded observational trial. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 28:1.
Crossref
Ignacio Blanco, Isidro Diego, Patricia Bueno, Sergio Pérez-Holanda, Francisco Casas-Maldonado & Marc Miravitlles. (2020) Prevalence of α 1 -antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review . European Respiratory Review 29:157, pages 200014.
Crossref
Huan Liu, Suozhong Chen, Manqing Hou & Liang He. (2019) Improved inverse distance weighting method application considering spatial autocorrelation in 3D geological modeling. Earth Science Informatics 13:3, pages 619-632.
Crossref
Ruxandra Ulmeanu, Ariadna Petronela Fildan, Ruxandra Mioara Rajnoveanu, Ovidiu Fira-Mladinescu, Claudia Toma, Roxana Maria Nemes, Emanuela Tudorache, Cristian Oancea & Florin Mihaltan. (2020) Romanian clinical guideline for diagnosis and treatment of COPD. Journal of International Medical Research 48:8, pages 030006052094690.
Crossref
Juan A. Riesco, María Hidalgo, David Chipayo, José J. Gómez & Fernando Zaragozá. (2020) Profile of Cardiovascular Disease Patients Who are Diagnosed with COPD in a Smoking-Cessation Unit. Advances in Therapy 37:8, pages 3562-3570.
Crossref
Victor Olsavszky, Mihnea Dosius, Cristian Vladescu & Johannes Benecke. (2020) Time Series Analysis and Forecasting with Automated Machine Learning on a National ICD-10 Database. International Journal of Environmental Research and Public Health 17:14, pages 4979.
Crossref
Maribel Rodríguez-Aguilar, Lorena Díaz de León-Martínez, Patricia Gorocica-Rosete, Rogelio Pérez Padilla, Ireri Thirión-Romero, Omar Ornelas-Rebolledo & Rogelio Flores-Ramírez. (2020) Identification of breath-prints for the COPD detection associated with smoking and household air pollution by electronic nose. Respiratory Medicine 163, pages 105901.
Crossref
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sabariah Noor Harun, Shahid Shah & Sameen Abbas. (2019) The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. The European Journal of Health Economics 21:2, pages 181-194.
Crossref
Ryoji Mikayama, Takashi Shirasaka, Hidetake Yabuuchi, Yuki Sakai, Tsukasa Kojima, Masatoshi Kondo, Hideki Yoshikawa & Toyoyuki Kato. (2020) Effect of scan mode and focal spot size in airway dimension measurements for ultra-high-resolution computed tomography of chronic obstructive pulmonary disease: A COPDGene phantom study. Physica Medica 70, pages 102-108.
Crossref
Zeinab Neisani Samani, Mohammad Karimi & Aliasghar Alesheikh. (2020) Environmental and infrastructural effects on respiratory disease exacerbation: a LBSN and ANN-based spatio-temporal modelling. Environmental Monitoring and Assessment 192:2.
Crossref
Pietro Pirina, Elisabetta Zinellu, Marco Martinetti, Claudia Spada, Barbara Piras, Claudia Collu & Alessandro Giuseppe Fois. (2020) Treatment of COPD and COPD–heart failure comorbidity in primary care in different stages of the disease. Primary Health Care Research & Development 21.
Crossref
Mariya Marushchak, Khrystyna Maksiv, Inna Krynytska, Olha Dutchak & Nina Behosh. (2019) The Severity of Oxidative Stress in Comorbid Chronic Obstructive Pulmonary Disease (COPD) and Hypertension: Does it Depend On ACE and AGT Gene Polymorphisms?. Journal of Medicine and Life 12:4, pages 426-434.
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
David M.G. Halpin, Bartolome R. Celli, Gerard J. Criner, Peter Frith, M. Victorina López Varela, Sundeep Salvi, Claus F. Vogelmeier, Ronchang Chen, Kevin Mortimer, Maria Montes de Oca, Zaurbek Aisanov, Daniel Obaseki, Rebecca Decker & Alvar Agusti. (2019) It is time for the world to take COPD seriously: a statement from the GOLD board of directors. European Respiratory Journal 54:1, pages 1900914.
Crossref
Ignacio Blanco, Isidro Diego, Patricia Bueno, Francisco Casas-Maldonado & Marc Miravitlles. (2019) Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps. European Respiratory Journal 54:1, pages 1900610.
Crossref
H. van der Molen, G. de Groene, C. Hulshof & M. Frings-Dresen. (2018) Association between Work and Chronic Obstructive Pulmonary Disease (COPD). Journal of Clinical Medicine 7:10, pages 335.
Crossref
Adolfo Domenech, Ana Muñoz-Montiel, Natalia García-Casares, José Rioja, Pedro Ruiz-Esteban, Patricia Gutierrez- Castaño, María Jesús Prunera Pardell, Casilda Olveira, Pedro Valdivielso & Miguel Ángel Sánchez-Chaparro. (2018) High risk of subclinical atherosclerosis in COPD exacerbator phenotype. Respiratory Medicine 141, pages 165-171.
Crossref